Outset Medical Share Price (NASDAQ: OM)

$13.91

▲

-0.01

(-0.07%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Outset Medical Stock chart to analyse performance

Outset Medical stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$13.85
Today's High:$14.22
$13.91
0.43%
Downside
Day's Volatility :2.6%
Upside
2.18%
52 Weeks Low:$5.85
52 Weeks High:$25.35
$13.91
57.94%
Downside
52 Weeks Volatility :76.92%
Upside
45.13%

Outset Medical Stock Returns

Period	Outset Medical Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-21.95%	3.6%	0.0%
6 Months	38.78%	-7.7%	0.0%
1 Year	75.6%	-12.6%	0.0%
3 Years	-94.73%	10.2%	-4.1%

Outset Medical Inc Key Stats

Check Outset Medical key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$13.92
Open	$13.85
Today's High	$14.22
Today's Low	$13.85
Market Capitalization	$248.0M
Today's Volume	$541.3K
52 Week High	$25.35
52 Week Low	$5.85
Revenue TTM	$119.3M
EBITDA	$-70.9M
Earnings Per Share (EPS)	$-18.75
Profit Margin	-82.06%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-87.65%

Stock Returns calculator for Outset Medical Stock including INR - Dollar returns

The Outset Medical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Outset Medical investment value today

Current value as on today

₹1,80,915

Returns

₹80,915

(+80.92%)

Returns from Outset Medical Stock

₹75,631 (+75.63%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Outset Medical Stock

60%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Outset Medical Stock from India on INDmoney has increased by 60% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Outset Medical Inc

Name
Holdings %
Name
Holdings %
FMR Inc
14.62%
Partner Fund Management LP
9.37%
Durable Capital Partners LP
9.33%
T. Rowe Price Investment Management,Inc.
9.14%
Alyeska Investment Group, L.P.
8.24%
Woodline Partners LP
7.46%

Analyst Recommendation on Outset Medical Stock

Rating

Trend

Buy

68%Buy

25%Hold

6%Sell

Based on 16 Wall street analysts offering stock ratings for Outset Medical(by analysts ranked 0 to 5 stars)

Outset Medical Share Price Target

What analysts predicted

Upside of 85.12%

Target:

$25.75

Current:

$13.91

Outset Medical share price target is $25.75, a slight Upside of 85.12% compared to current price of $13.91 as per analysts' prediction.

Outset Medical Stock Insights

Price Movement
In the last 3 months, OM stock has moved down by -20.9%
Increasing Revenue
Revenue is up for the last 5 quarters, 27.38M → 31.41M (in $), with an average increase of 3.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -25.78M → -18.54M (in $), with an average increase of 39.1% per quarter
OM vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 161.7% return, outperforming this stock by 256.6%

Outset Medical Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$15.1M	↑ 651.27%
Net Income	$-68.3M	↑ 37.2%
Net Profit Margin	-452.97%	↑ 2027.35%

	FY20	Y/Y Change
Revenue	$49.9M	↑ 231.18%
Net Income	$-120.7M	↑ 76.72%
Net Profit Margin	-241.71%	↑ 211.26%

	FY21	Y/Y Change
Revenue	$102.6M	↑ 105.47%
Net Income	$-131.9M	↑ 9.31%
Net Profit Margin	-128.59%	↑ 113.12%

	FY22	Y/Y Change
Revenue	$115.4M	↑ 12.45%
Net Income	$-163.0M	↑ 23.51%
Net Profit Margin	-141.24%	↓ 12.65%

	FY23	Y/Y Change
Revenue	$130.4M	↑ 13.0%
Net Income	$-172.8M	↑ 6.04%
Net Profit Margin	-132.54%	↑ 8.7%

	FY24	Y/Y Change
Revenue	$113.7M	↓ 12.8%
Net Income	$-128.0M	↓ 25.94%
Net Profit Margin	-112.57%	↑ 19.97%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$28.2M	↓ 7.67%
Net Income	$-39.9M	↑ 3.48%
Net Profit Margin	-141.81%	↓ 15.28%

	Q2 FY24	Q/Q Change
Revenue	$27.4M	↓ 2.77%
Net Income	$-34.5M	↓ 13.74%
Net Profit Margin	-125.8%	↑ 16.01%

	Q3 FY24	Q/Q Change
Revenue	$28.7M	↑ 4.67%
Net Income	$-27.9M	↓ 18.91%
Net Profit Margin	-97.47%	↑ 28.33%

	Q4 FY24	Q/Q Change
Revenue	$29.5M	↑ 2.79%
Net Income	$-25.6M	↓ 8.24%
Net Profit Margin	-87.01%	↑ 10.46%

	Q1 FY25	Q/Q Change
Revenue	$29.8M	↑ 0.97%
Net Income	$-25.8M	↑ 0.57%
Net Profit Margin	-86.66%	↑ 0.35%

	Q2 FY25	Q/Q Change
Revenue	$31.4M	↑ 5.6%
Net Income	$-18.5M	↓ 28.09%
Net Profit Margin	-59.01%	↑ 27.65%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$-17.8M	↑ 191.12%

	FY20	Y/Y Change
Profit	$-13.0M	↓ 26.77%

	FY21	Y/Y Change
Profit	$7.6M	↓ 158.36%

	FY22	Y/Y Change
Profit	$17.8M	↑ 134.4%

	FY23	Y/Y Change
Profit	$29.0M	↑ 62.62%

	FY24	Y/Y Change
Profit	$38.6M	↑ 32.98%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$8.2M	↑ 6.52%

	Q2 FY24	Q/Q Change
Profit	$9.8M	↑ 19.07%

	Q3 FY24	Q/Q Change
Profit	$9.8M	↑ 0.39%

	Q4 FY24	Q/Q Change
Profit	$10.7M	↑ 9.44%

	Q1 FY25	Q/Q Change
Profit	$11.1M	↑ 2.97%

	Q2 FY25	Q/Q Change
Profit	$11.9M	↑ 7.24%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-70.3M	↑ 51.35%
Investing Cash Flow	$74.3M	↓ 208.03%
Financing Cash Flow	$249.0K	↓ 99.82%

	FY20	Y/Y Change
Operating Cash Flow	$-99.0M	↑ 40.86%
Investing Cash Flow	$3.9M	↓ 94.69%
Financing Cash Flow	$385.7M	↑ 154792.37%

	FY21	Y/Y Change
Operating Cash Flow	$-130.3M	↑ 31.56%
Investing Cash Flow	$-142.5M	↓ 3710.51%
Financing Cash Flow	$160.1M	↓ 58.48%

	FY22	Y/Y Change
Operating Cash Flow	$-145.7M	↑ 11.87%
Investing Cash Flow	$-66.3M	↓ 53.48%
Financing Cash Flow	$72.9M	↓ 54.48%

	FY23	Y/Y Change
Operating Cash Flow	$-131.4M	↓ 9.85%
Investing Cash Flow	$83.0M	↓ 225.24%
Financing Cash Flow	$43.7M	↓ 40.12%

	FY24	Y/Y Change
Operating Cash Flow	$-116.3M	↓ 11.47%
Investing Cash Flow	$103.9M	↑ 25.19%
Financing Cash Flow	$67.9M	↑ 55.48%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-45.9M	↑ 87.84%
Investing Cash Flow	$-59.0M	↓ 352.0%
Financing Cash Flow	$68.6M	↑ 106.48%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-33.3M	↓ 27.39%
Investing Cash Flow	$38.9M	↓ 165.97%
Financing Cash Flow	$77.0K	↓ 99.89%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-20.6M	↓ 38.3%
Investing Cash Flow	$15.9M	↓ 59.23%
Financing Cash Flow	$121.0K	↑ 57.14%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-16.5M	↓ 19.84%
Investing Cash Flow	$108.2M	↑ 581.28%
Financing Cash Flow	$-938.0K	↓ 875.21%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-25.7M	↑ 55.65%
Investing Cash Flow	$-78.1M	↓ 172.19%
Financing Cash Flow	$55.7M	↓ 6033.48%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-4.8M	↓ 81.21%
Investing Cash Flow	$-31.2M	↓ 60.09%
Financing Cash Flow	$-384.0K	↓ 100.69%

Outset Medical Technicals Summary

Sell

Neutral

Buy

Outset Medical is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Outset Medical Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Outset Medical Inc	-7.58%	38.78%	75.6%	-94.73%	-98.47%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	4.24%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Outset Medical Inc	NA	NA	NA	-4.3	-0.88	-0.16	NA	8.5
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Outset Medical Inc	Buy	$248.0M	-98.47%	NA	-82.06%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Outset Medical Inc

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Organization	Outset Medical
Employees	354
CEO	Ms. Leslie L. Trigg
Industry	Health Technology

Key Management of Outset Medical Inc

Name	Title
Ms. Leslie L. Trigg	President, CEO & Chairman
Mr. John L. Brottem J.D.	General Counsel & Secretary
Ms. Renee M. Gaeta	CFO, Principal Financial Officer & Principal Accounting Officer
Mr. Marc Nash	Senior Vice President of Operations and R&D
Mr. James S. Mazzola	Head of Investor Relations
Ms. Laura Romike	Senior Vice President of Sales
Amelia Merrill	VP of People Operations & Culture
Dr. Michael Aragon M.D.	Chief Medical Officer

Important FAQs about investing in OM Stock from India :

What is Outset Medical share price today?

Outset Medical share price today is $13.91 as on August 30, 2025 at 1:29 am IST at the close of the market. Outset Medical share today touched a day high of $14.22 and a low of $13.85.

What is the 52 week high and 52 week low for Outset Medical share?

Outset Medical share touched a 52 week high of $25.35 and a 52 week low of $5.85. Outset Medical stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $13.91, lower by 45.13% versus the 52 week high.

How to invest in Outset Medical Stock (OM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Outset Medical on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Outset Medical Shares that will get you 0.1078 shares as per Outset Medical share price of $13.91 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Outset Medical Stock (OM) from India?

Indian investors can start investing in Outset Medical (OM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Outset Medical stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Outset Medical share’s latest price of $13.91 as on August 30, 2025 at 1:29 am IST, you will get 0.7189 shares of Outset Medical. Learn more about fractional shares .

What are the returns that Outset Medical has given to Indian investors in the last 5 years?

Outset Medical stock has given -98.47% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?